Spots Global Cancer Trial Database for everolimus (rad001) , afinitor®
Every month we try and update this database with for everolimus (rad001) , afinitor® cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 | NCT01419639 | Neurofibromatos... | Everolimus (RAD... | 3 Years - | NYU Langone Health | |
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 | NCT01419639 | Neurofibromatos... | Everolimus (RAD... | 3 Years - | NYU Langone Health | |
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 | NCT01419639 | Neurofibromatos... | Everolimus (RAD... | 3 Years - | NYU Langone Health |